Search results for "Diarrhea"

showing 10 items of 152 documents

Prospective multicenter trial of capsule endoscopy in patients with chronic abdominal pain, diarrhea and other signs and symptoms (CEDAP-Plus Study)

2007

Background On the basis of the published data, capsule endoscopy cannot be recommended in patients whose only symptom is chronic abdominal pain. The present study therefore focused on the diagnostic yield of capsule endoscopy in patients with chronic abdominal pain who were also suffering from additional symptoms. Patients and methods A total of 50 patients with chronic abdominal pain, plus other symptoms singly or in combination were enrolled in this prospective multicenter trial. The "plus" symptoms or signs consisted of weight loss (> 10 % of body weight), inflammation shown by laboratory tests, chronic anemia, or suspected mid-gastrointestinal bleeding. Chronic diarrhea was recorded if …

AdultDiarrheaMaleEnteroscopymedicine.medical_specialtyGastrointestinal bleedingAdolescentAnemiaBiopsyAdenocarcinomaCapsule EndoscopyGastroenterologylaw.inventionDiagnosis DifferentialCrohn DiseaseCapsule endoscopylawInternal medicineMulticenter trialIntestinal NeoplasmsOdds RatiomedicineHumansProspective StudiesProspective cohort studyAgedbusiness.industryGastroenterologyEquipment DesignOdds ratioMiddle AgedPrognosismedicine.diseaseAbdominal PainCeliac Diseasemedicine.anatomical_structureCapsule EndoscopesChronic DiseaseAbdomenFemalebusinessFollow-Up StudiesEndoscopy
researchProduct

Chronic Intestinal Infection due to Subgenus F Type 40 Adenovirus in a Patient with AIDS

1997

A case of chronic intestinal infection due to adenovirus type 40 lasting for 13 months in a patient with AIDS is described. Adenovirus particles were detected by electron microscopy in biopsy samples taken from the duodenum 3 months after the onset of diarrhoea. The virus was identified as adenovirus type 40 in stool samples by ELISA monoclonal antibodies to adenovirus group antigen (MAd-g2) and types 40 and 41 (MA 40-1 and MA 41-1). No other enteropathogens were found. These data support a causal relationship between adenovirus 40 and the gastrointestinal symptoms of the patient. This is the first reported case of intestinal infection caused by adenovirus type 40 in a patient with AIDS.

AdultDiarrheaMaleMicrobiology (medical)DuodenumOpportunistic infectionvirusesBiologymedicine.disease_causeVirusAdenovirus Infections HumanFecesAntigenImmunopathologyBiopsymedicineHumansDuodenal DiseasesIntestinal MucosaAIDS-Related Opportunistic InfectionsGeneral Immunology and Microbiologymedicine.diagnostic_testAdenoviruses HumanGeneral Medicinemedicine.diseaseVirologyAdenoviridaeIntestinal DiseasesMicroscopy ElectronDiarrheaInfectious DiseasesChronic DiseaseImmunologyViral diseasemedicine.symptomScandinavian Journal of Infectious Diseases
researchProduct

Gallstone dissolution with chenodeoxycholic acid. A clinical study.

1980

Out of 95 patients with radiolucent gallstones who enrolled in a clinical study with chenodeoxycholic acid (CDC) for gallstone dissolution 75 patients with cholecystolithiasis completed 12 months of treatment. As a side effect 31% of patients reported intermittent diarrhea which did not cause cessation of therapy or missing of work. The incidence of biliary colic was markedly decreased during treatment in comparison to the rate in the year before. From more than 20 laboratory values checked before start and every 3 months during therapy only aminotransferases increased up to 3 fold in 20% of patients. gamma-GT elevated in 31% of patients before treatment improved in half of these patients d…

AdultDiarrheaMalemedicine.medical_specialtyAdolescentBiliary colicBody weightChenodeoxycholic AcidGastroenterologyClinical studyGallstone dissolutionchemistry.chemical_compoundCholelithiasisChenodeoxycholic acidInternal medicineDrug DiscoverymedicineHumansIn patientGenetics (clinical)AgedDiminutionDose-Response Relationship Drugbusiness.industryBody WeightGeneral MedicineGallstonesMiddle Agedmedicine.diseasechemistrySolubilityMolecular MedicineFemalemedicine.symptombusinessConstipationKlinische Wochenschrift
researchProduct

The appropriateness of colonoscopies at a teaching hospital: magnitude, associated factors, and comparison of EPAGE and EPAGE-II criteria.

2011

Background The growing demand for colonoscopies and inappropriate colonoscopies have become a significant problem for health care. Objectives To assess the appropriateness of colonoscopies and to analyze the association with some clinical and organizational factors. To compare the results of the European Panel of Appropriateness of Gastrointestinal Endoscopy (EPAGE) and the EPAGE-II criteria. Design Cross-sectional study. Setting Endoscopy unit of a teaching hospital in Spain. Patients Patients referred for colonoscopy, excluding urgent, therapeutic indications, and poor cleansing. Main Outcome Measurements Appropriateness of colonoscopies according to the EPAGE criteria. Results From 749 c…

AdultDiarrheaMalemedicine.medical_specialtyAdolescentColorectal cancerCross-sectional studyMEDLINEColonoscopyColonic PolypsUnnecessary ProceduresColonic polypectomyYoung AdultCrohn DiseasemedicineHumansRadiology Nuclear Medicine and imagingMedical diagnosisHospitals TeachingReferral and ConsultationAgedAged 80 and overChi-Square Distributionmedicine.diagnostic_testbusiness.industryGastroenterologyColonoscopyMiddle Agedmedicine.diseaseHematocheziaSurgeryCross-Sectional StudiesSpainEmergency medicinePractice Guidelines as TopicColitis UlcerativeFemaleGuideline Adherencemedicine.symptombusinessColorectal NeoplasmsGastrointestinal HemorrhageChi-squared distributionSentinel SurveillanceGastrointestinal endoscopy
researchProduct

Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients.

1995

In a significant number of patients affected by the irritable bowel syndrome, an adverse reaction to food is proposed to be a causative factor. A diet that eliminates the offending foods is the obvious treatment for such adverse reactions. Compliance with a dietetic regimen is often poor and sometimes not completely free from risks.Since the diarrheic type of irritable bowel syndrome seems mainly affected by food intolerance, and previous observations suggested that oral cromolyn sodium is effective in such patients, a multicenter therapeutic trial in the diarrheic type of irritable bowel syndrome was carried out in 346 of 409 patients with this disease, to evaluate the effects of oral crom…

AdultDiarrheaMalemedicine.medical_specialtyAdolescentmedicine.medical_treatmentAdministration OralColonic Diseases FunctionalGastroenterologyOral administrationInternal medicineElimination dietAnti-Allergic AgentsCromolyn SodiummedicineHumansAdverse effectIrritable bowel syndromeAgedAged 80 and overChemotherapybusiness.industrydigestive oral and skin physiologyGastroenterologyCromolyn SodiumMiddle Agedmedicine.diseasePrognosisDiarrheaTreatment OutcomeMulticenter studyFemalemedicine.symptombusinessFood HypersensitivityScandinavian journal of gastroenterology
researchProduct

Effect of loperamide on jejunal electrolyte and water transport, prostaglandin E 2-induced secretion and intestinal transit time in man

1991

Jejunal perfusion was performed in 12 healthy volunteers to evaluate the dose dependent effects of loperamide on intestinal absorption, stimulated secretion and transit. In 6 volunteers intestinal perfusion of the jejunal segment with isotonic NaCl solution was followed by addition of loperamide in increasing doses (2–8 mg·l−1). The volunteers were pretreated with 1 mg·l−1 prostaglandin E2 (PgE2) in the perfusate before addition of 4 mg·l−1 loperamide. Phenolsulphonphtalein (PSP) boluses (2 ml) were given to measure mean transit time (MTT). Loperamide 2 mg·l−1 converted the minor secretion after perfusion with the standard solution (water −1.45 ml·min−1, Na −0.09 and Cl −0.04 mmol·min−1) to…

AdultDiarrheaMalemedicine.medical_specialtyLoperamideAdolescentAbsorption (skin)LoperamideDinoprostoneIntestinal absorptionJejunumChloridesInternal medicinemedicineHumansPharmacology (medical)Prostaglandin E2Gastrointestinal TransitPharmacologyWater transportDose-Response Relationship DrugChemistrySodiumBiological TransportGeneral MedicineWater-Electrolyte BalanceJejunumEndocrinologymedicine.anatomical_structureIntestinal AbsorptionMechanism of actionmedicine.symptomPerfusionmedicine.drugEuropean Journal of Clinical Pharmacology
researchProduct

Cetuximab plus cisplatin–5-fluorouracil versus cisplatin–5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a ra…

2009

Abstract Background This study assessed the activity of the mAb cetuximab in combination with cisplatin and 5-fluorouracil (5-FU) in advanced esophageal squamous cell carcinoma. Patients and methods For a maximum of six 29-day cycles, patients received cisplatin 100 mg/m2, day 1, plus 5-FU 1000 mg/m2, days 1–5 (CF), either alone or in combination with cetuximab (CET–CF; 400 mg/m2 initial dose followed by 250 mg/m2 weekly thereafter). The primary end point was tumor response. Tumor material was obtained for analysis of KRAS mutation status. Results Sixty-two eligible patients were included, 32 receiving CET–CF and 30 CF. Cetuximab did not exacerbate grade 3/4 toxicity, except for rash (6% ve…

AdultDiarrheaMalemedicine.medical_specialtyNeutropeniaTime FactorsEsophageal NeoplasmsCetuximabPhases of clinical researchKaplan-Meier EstimateAntibodies Monoclonal Humanizedmedicine.disease_causeGastroenterologyDisease-Free SurvivalInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProgression-free survivalAgedCross-Over StudiesDose-Response Relationship DrugCetuximabbusiness.industryAntibodies MonoclonalNauseaHematologyMiddle AgedCombined Modality TherapySurvival AnalysisChemotherapy regimenSurgeryTreatment OutcomeOncologyEpidermoid carcinomaFluorouracilResponse Evaluation Criteria in Solid TumorsCarcinoma Squamous CellFemaleFluorouracilKRASCisplatinbusinessFollow-Up Studiesmedicine.drugAnnals of Oncology
researchProduct

Pharmacokinetics of Oral Posaconazole in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Graft-versus-Host Disease

2007

Study Objective. To analyze the pharmacokinetics of posaconazole administered as prophylaxis for invasive fungal infections in recipients of hematopoietic stem cell transplants (HSCTs) who have graft-versus-host disease (GVHD). Design. Pharmacokinetic analysis in a subset of posaconazole-treated patients from a large, multicenter, phase III, randomized, double-blind, double-dummy, parallel-group trial that compared posaconazole with fluconazole. Setting. Ninety international medical centers. Patients. The subset of patients comprised 246 HSCT recipients for whom pharmacokinetic data were available. Intervention. All patients received posaconazole 200 mg oral suspension 3 times/day for a max…

AdultDiarrheaMalemedicine.medical_specialtyPosaconazoleAntifungal AgentsAdolescentCmaxGraft vs Host DiseaseOpportunistic InfectionsGastroenterologySex FactorsDouble-Blind MethodPharmacokineticsOral administrationInternal medicinemedicineHumansTransplantation HomologousPharmacology (medical)MycosisAgedbusiness.industryBody WeightRacial GroupsAge FactorsHematopoietic Stem Cell TransplantationMiddle AgedTriazolesmedicine.diseaseSurgeryTransplantationGraft-versus-host diseaseMycosesAcute DiseaseChronic DiseaseFemalebusinessFluconazolemedicine.drugPharmacotherapy
researchProduct

Diagnostic Accuracy of Fecal Calprotectin Assay in Distinguishing Organic Causes of Chronic Diarrhea from Irritable Bowel Syndrome: A Prospective Stu…

2003

AbstractBackground: Fecal calprotectin (FC) has been proposed as a marker of inflammatory bowel disease (IBD), but few studies have evaluated its usefulness in patients with chronic diarrhea of various causes. We evaluated the diagnostic accuracy of a FC assay in identifying “organic” causes of chronic diarrhea in consecutive adults and children.Methods: We consecutively enrolled 70 adult patients (30 males, 40 females; median age, 35 years) and 50 children (20 males, 30 females; median age, 3.5 years) with chronic diarrhea of unknown origin. All patients underwent a complete work-up to identify the causes of chronic diarrhea. FC was measured by ELISA.Results: In adult patients, FC showed 6…

AdultDiarrheaMalemedicine.medical_specialtySettore MED/09 - Medicina InternaAdolescentClinical BiochemistryColonic Diseases FunctionalInflammatory bowel diseaseGastroenterologyCoeliac diseaseDiagnosis DifferentialFecesInternal medicinePositive predicative valuemedicineHumansChildIrritable bowel syndromeAgedbusiness.industryBiochemistry (medical)Adolescent; Adult; Aged; Child; Child Preschool; Chronic Disease; Colonic Diseases Functional; Diagnosis Differential; Diarrhea; Feces; Female; Humans; Infant; Leukocyte L1 Antigen Complex; Male; Middle AgedInfantMiddle Agedmedicine.diseaseUlcerative colitisFood intoleranceDiarrheaChild PreschoolChronic DiseaseFeceFemalemedicine.symptomCalprotectinbusinessLeukocyte L1 Antigen ComplexHumanClinical Chemistry
researchProduct

Fecal Calprotectin in Clinical Practice

2012

Background: Surrogate markers of colorectal inflammation are increasingly being recognized as important in differentiating organic from functional intestinal disorders. Fecal calprotectin (FC) can be easily measured in the stool, being released by leukocytes in inflammatory conditions. Aim: We evaluated FC as an index of inflammation in consecutive outpatients referred for colonoscopy for chronic, nonbloody diarrhea. Methods: Stool specimens of 346 outpatients with chronic, nonbloody diarrhea, referred for colonoscopy, were measured for FC levels. The proportion of patients correctly diagnosed with the test and the relationship with endoscopic and histologic findings were measured. Results:…

AdultDiarrheaMalemedicine.medical_specialtySettore MED/09 - Medicina InternaAdolescentdiarrheaColonoscopyInflammationSettore MED/08 - Anatomia PatologicaSensitivity and SpecificityGastroenterologyFecesYoung AdultPredictive Value of TestsInternal medicinemedicineHumansScreening toolProspective StudiesFecesAgedAged 80 and overInflammationSettore MED/12 - Gastroenterologiamedicine.diagnostic_testbusiness.industryGastroenterologyHistologyColonoscopyMiddle AgedEndoscopyDiarrheaChronic DiseaseFemalemedicine.symptomCalprotectinbusinessLeukocyte L1 Antigen ComplexJournal of Clinical Gastroenterology
researchProduct